“Tralokinumab Real-World Patient-Reported Outcomes in Moderate-to-Severe Atopic Dermatitis Adult Patients in the United States: 6-Month Interim Analysis”. SKIN The Journal of Cutaneous Medicine, vol. 8, no. 1, Jan. 2024, p. s318, https://doi.org/10.25251/skin.8.supp.318.